These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4906100)

  • 1. [Rifomycin in treatment of chronic tuberculosis with bacilli resistant to standard medications].
    Nitti V; Delli Veneri F; Marra A
    Acta Tuberc Pneumol Belg; 1969; 60(3):455-65. PubMed ID: 4906100
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin].
    Grassi C
    Acta Tuberc Pneumol Belg; 1969; 60(3):450-4. PubMed ID: 4906991
    [No Abstract]   [Full Text] [Related]  

  • 5. Methods of clinical evaluation of rifampicin-activity.
    Trendelenburg F
    Acta Tuberc Pneumol Belg; 1969; 60(3):432-6. PubMed ID: 4906099
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of rifampicin, ethambutol and PAS in short-term monotherapy. Preliminary results of the third cooperative study of the WATL.
    Schütz I
    Acta Tuberc Pneumol Belg; 1969; 60(3):437-41. PubMed ID: 4906990
    [No Abstract]   [Full Text] [Related]  

  • 7. [3 cases of treatment of advanced tuberculosis with multiresistant bacilli by combined rifomycin-ethambutol].
    Hennebert A
    Acta Tuberc Pneumol Belg; 1969; 60(3):507-12. PubMed ID: 5371675
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1969; 69():43-53. PubMed ID: 4906373
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study on rifomycin in resumption of treatment of pulmonary tuberculosis cases with polyresistant bacilli].
    Prignot J; Gyselen A; Cosemans J; De Brabandere R; Verbist L; Simon-Pouthier F
    Acta Tuberc Pneumol Belg; 1969; 60(3):487-95. PubMed ID: 4906102
    [No Abstract]   [Full Text] [Related]  

  • 11. [Internal medicine treatment of pulmonary tuberculosis].
    Schaich W
    Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of rifampicin on the treatment of tuberculosis.
    Bayliss CG
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():140-3. PubMed ID: 4467983
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current views on drug treatment of tuberculosis].
    Repo K; Riska N
    Duodecim; 1970; 86(21):1268-78. PubMed ID: 5490929
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical tolerance of rifampycin administered alone or in combination with other antitubercular drugs].
    Carratù L; Sonaglioni F; Natali P
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):399-410. PubMed ID: 5306592
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
    Meissner G
    Acta Tuberc Pneumol Belg; 1969; 60(3):554-6. PubMed ID: 4906103
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new and powerful anti-tubercular drug: rifampicin].
    Chenebault J
    Voen Med Zh; 1970 Aug; 8():465-70. PubMed ID: 5515347
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new and powerful anti-tubercular drug: rifampicin].
    Chenebault J
    Maroc Med; 1970 Jul; 537():465-70. PubMed ID: 5503096
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changing picture of tuberculosis during a decade].
    Tveit J
    Tidsskr Nor Laegeforen; 1971 Apr; 91(12):866-8. PubMed ID: 5554775
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 20. [Our initial clinical experience with rifomycin].
    Böszörményi M; Fauszt I; Károlyi A; Seri I; Vámos K
    Acta Tuberc Pneumol Belg; 1969; 60(3):471-7. PubMed ID: 4906101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.